Log In
Print
BCIQ
Print
Print this Print this
 

PST-900

  Manage Alerts
Collapse Summary General Information
Company Pharmasum Therapeutics A/S
DescriptionDual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) inhibitor
Molecular Target Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD) in Down syndrome patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today